1
814 Journal of Natural Products, 2010, Vol. 73, No. 11
Tripathi et al.
synthesized in a similar manner from D-Ile, D-allo-Ile, and L-allo-Ile,
respectively.
In Vitro Antimalarial Assay. Plasmodium falciparum drug-sensitive
1
3,14
NF54 and chloroquine-resistant K1 strains were cultivated in a variation
1
7,18
Absolute Configuration of Hila Moiety in 1. Determination of the
absolute configuration for the Hila residue in 1 was accomplished by
a modified method based on Mosher’s reagents and analysis using
LCMS. Lagunamide A (1, 1.0 mg) was hydrolyzed in 6 N HCl (1 mL)
in a sealed reaction vial at 110 °C for 18 h. Trace HCl was removed
of the medium previously described,
supplemented with 0.5% ALBUMAX II, Hepes (25 mM), NaHCO
consisting of RPMI 1640
3
(25 mM, pH 7.3), hypoxanthine (0.36 mM), and neomycin (100 µg/
mL). Human erythrocytes served as host cells. Cultures were maintained
in an atmosphere of O :CO :N (3:4:93) in humidified modular
2 2 2
under a stream of N
2
gas, the resulting hydrolysate was divided into
chambers at 37 °C. Compounds were dissolved in DMSO (10 mM),
diluted in hypoxanthine-free culture medium, and titrated in duplicates
over a 64-fold range in 96-well plates. Infected erythrocytes (1.25%
final hematocrit and 0.3% final parasitemia) were added into the wells.
two equal portions (0.5 mg each), and pyridine (0.5 mL) was added to
each. R-Methoxy-R-trifluoromethylphenylacetic acid (R-MTPACl) (2.5
mg) was added to one portion and S-MTPACl (2.5 mg) to the other.
The reaction was carried out for 10 h at rt, and the solvent was
3
After 48 h incubation, [ H]hypoxanthine (0.5 µCi) was added per well
evaporated under N
each) was derivatized with either R- or S-MTPACl (1.0 mg each in
.5 mL of pyridine). All derivatized samples were subjected to reversed-
2
. In a similar manner, each isomer of Hila (0.5 mg
and plates were incubated for an additional 24 h. Parasites were
harvested onto glass-fiber filters, and radioactivity was counted using
a Betaplate liquid scintillation counter (Wallac, Zurich). The results
were recorded and expressed as a percentage of the untreated controls.
0
phase LCMS (Agilent 1100 series) (Phenomenex, Luna, 150 × 2.0
mm, 5 µm, 100 Å; MeCN in 0.1% (v/v) aqueous HCOOH; at 0.20
mL/min) using a linear gradient (30-70% MeCN over 90 min). An
Agilent 1100 series MSD spectrometer was used for detection in API-
1
9
IC50 values were estimated by linear interpolation.
Acknowledgment. The authors would like to acknowledge NIE
AcRF (RI 8/05 TLT) for financial support. In addition, the authors thank
A. L. Ang (NSSE, NIE), S. G. Y. Lee (NSSE, NIE), C. C. Teo (NSSE,
NIE), and P. Gread (University of Waikato) for providing valuable
technical assistance as well as the Swiss Tropical and Public Health
Institute, Switzerland, for performing the antimalarial assay on the
lagunamides.
ES (negative mode). The retention times and ESIMS product ions (t
R
in min) of the S-MTPACl-monoderivatized standard hydroxy amino
acids were observed to be L-Hila (44.1 min), L-allo-Hila (44.5 min),
D-Hila () R-MTPACl-derivatized L-Hila, 42.9 min), and D-allo-Hila
(
) R-MTPACl-derivatized L-allo-Hila, 43.4 min). Consequently, the
absolute configuration of the Hila moiety in the hydrolysate of 1
derivatized with S-MTPACl was confirmed as D-allo-Hila since it eluted
at 43.4 min.
Supporting Information Available: H, 13C, and 2D NMR spectra
1
MTPA (r-Methoxy-r-Trifluoromethylphenylacetic Acid) Esters
of 1. Two portions of lagunamide A (1, 0.5 mg each) were reacted
with R- or S-MTPACl (5.0 mg) in pyridine (0.5 mL) for 10 h at rt, and
in CD OD for lagunamides A (1) and B (2) and biological data. This
material is available free of charge via the Internet at http://pubs.acs.org.
3
the solvent was then evaporated under N
2
. The corresponding esters
References and Notes
were subjected to NMR analysis.
1
S-MTPA Ester: H NMR (400 MHz, CD
H-36a), 2.015 (H-36b), 3.542 (H-37), 1.301 (H-38), 4.839 (H-39),
3
OD) δ 7.201 (H-35), 2.206
(1) (a) Gerwick, W. H.; Tan, L. T.; Sitachitta, N. In The Alkaloids.
Chemistry and Biology; Cordell, G. A., Ed.; Academic Press: San
Diego, 2001; Vol. 57, pp 75-184. (b) Tan, L. T. Phytochemistry 2007,
(
2
4
.248 (H-40), 1.207 (H-41a), 1.413 (H-41b), 0.918 (H-42), 1.907 (H-
6
8, 954–979.
3), 0.901 (H-44), 0.923 (H-45).
1
(2) Tan, L. T. J. Appl. Phycol. 2010, 22, 659–676.
R-MTPA Ester: H NMR (400 MHz, CD
3
OD) δ 7.223 (H-35),
(
3) Linington, R. G.; Clark, B. R.; Trimble, E. E.; Almanza, A.; Urena,
L. D.; Kyle, D. E.; Gerwick, W. H. J. Nat. Prod. 2009, 72, 14–17.
4) Tripathi, A.; Puddick, J.; Prinsep, M. R.; Lee, P. P. F.; Tan, L. T. J.
Nat. Prod. 2009, 72, 29–32.
2
3
.232 (H-36a), 2.047 (H-36b), 3.556 (H-37), 1.283 (H-38), 4.810 (H-
9), 2.236 (H-40), 1.191 (H-41a), 1.401 (H-41b), 0.902 (H-42), 1.939
(
(
H-43), 0.881 (H-44), 0.891 (H-45).
Antiswarming Assay Based on Pseudomonas aeruginosa PA01.
(5) Tripathi, A.; Puddick, J.; Prinsep, M. R.; Lee, P. P. F.; Tan, L. T.
Phytochemistry 2010, 71, 307–311.
(6) Han, B.; Gross, H.; Goeger, D. E.; Mooberry, S. L.; Gerwick, W. H.
J. Nat. Prod. 2006, 69, 572–575.
An antiswarming assay based on the bacteria P. aeruginosa PA01 was
carried out using either lagunamide A or B (0.5 mg) added into 5 mL
of molten STA (soft top agar) [constituted with 200 mL of deionized
(
(
(
7) Nakao, Y.; Yoshida, W. Y.; Takada, Y.; Kimura, J.; Yang, L.;
Mooberry, S. L.; Scheuer, P. J. J. Nat. Prod. 2004, 67, 1332–1340.
8) Williams, P. G.; Yoshida, W. Y.; Quon, M. K.; Moore, R. E.; Paul,
V. J. J. Nat. Prod. 2003, 66, 1545–1549.
9) Couperus, P. A.; Clague, A. D. H.; van Dongen, J. P. C. Org. Magn.
Reson. 1976, 8, 426–431.
H
1
2
O, 1.3 g of agar (Technical agar # 3 Oxoid), 2 g of tryptone (Difco),
g of NaCl (Sigma)] and poured immediately over the surface of a
solidified Luria Bertani agar (40 g/L from MoBio) plate as an overlay.
Once the overlaid agar had solidified, the plate was point inoculated
with the bacterial strain (5 µL) and incubated (37 °C for 72 h). The
experiment was performed in triplicate along with a MeOH-treated plate
as a control, and the extent of swarming was determined by measuring
the area of the colony using a leaf surface meter (area meter AM200,
ADC Bioscientific Ltd.).
Cytotoxicity Assay. Test solutions were added to P388 murine
leukemia cells (ATCC CCL46) in a series of eight 2-fold dilutions,
and cells were then incubated (35 °C, 72 h). Media, solvents, cells,
and positive controls were included in each assay run. 3-(4,5-
Dimethylthiazoyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was
added to wells; then cells were incubated for a further 4 h. Cell viability
was determined by measurement of formazan production via a
spectrophotometer at 540 nm. The percentage inhibition of cell growth
was determined by comparison of test well absorbance to that of a
control, and a plot of logarithm of sample concentration versus
absorbance was used to determine the IC50 (ng/mL) value (concentration
of the test sample required to reduce the P388 cell line growth by 50%).
(10) Marfey, P. Carlsberg Res. Commun. 1984, 49, 591–596.
(11) Fuji, K.; Ikai, Y.; Mayumi, T.; Oka, H.; Sujuki, M.; Harada, K. I.
Anal. Chem. 1997, 69, 3346–3352.
(
12) Fujii, K.; Ikai, Y.; Oka, H.; Suzuki, M.; Harada, K. I. Anal. Chem.
1
997, 69, 5146–5151.
(
(
13) Mamer, O. A. Methods Enzymol. 2000, 324, 3–10.
14) Mamer, O. A.; Reimer, M. L. J. J. Biol. Chem. 1992, 267, 22141–
2
2147.
(
15) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem.
Soc. 1991, 113, 4092–4096.
(16) Fennell, B. J.; Carolan, S.; Pettit, G. R.; Bell, A. J. Antimicrob.
Chemother. 2003, 51, 833–841.
(
17) Dorn, A.; Stoffel, R.; Matile, H.; Bubendorf, A.; Ridley, R. G. Nature
1
995, 374, 269–271.
(18) Trager, W.; Jensen, J. B. Science 1976, 20, 673–675.
19) Huber, W.; Koella, J. Acta Trop. 1993, 55, 257–261.
(
NP100442X